A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
TWO women lose their lives to cervical cancer every day in the UK. Like all types of the disease, the earlier it’s caught, the better. Around 95 per cent of those diagnosed at stage 1 will ...
An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial published ...
The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...
Mai Elin Wehn, 41, was on holiday in Liverpool with her family when she found out her sister Vera Henriksen, 47, had cervical ...
In a bid to eliminate cervical cancer in Africa by 2030, Communication for Development and Advocacy Consult (CDA CONSULT) has ...
When symptoms do occur, they may include unusual vaginal bleeding (after intercourse, between periods, or post-menopause), ...
Mai Elin Wehn and Vera Henriksen couldn't believe it when they found out they both had cervical cancer – thankfully, one ...
RFK Jr. plans to keep collecting referral fees in lawsuits against the drug company Merck even if confirmed as HHS secretary, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback